Category: Case Study
Delivering a Registrational GI Trial Through Ongoing Protocol Shifts An emerging oncology biotech developing next-generation bispecific antibody therapies partnered with Catalyst Oncology to manage Read Now 
Accelerating Approval Pathway For Phase III Ovarian Cancer Trial A late-stage biotech was developing a combination therapy for a rare form of ovarian cancer. It is challenging to diagnose, difficult to treat due to its chemo-resistance, and at the time, there were no approved treatments specifically for this indication. Read Now 
Managing a Multiple CRO Relationship Transition A midsized biotech sponsor approached Catalyst Flex with the opportunity to increase biostatistics and data management work from staff augmentation services only to become their preferred biometrics provider. Read Now 
Expanding Relationship from Resourcing to Functional Preferred Provider A midsized biotech sponsor approached Catalyst Flex with the opportunity to increase biostatistics and data management work from staff augmentation services only to become their preferred biometrics provider. Read Now 
Niche CRO’s Growing Outsourcing Needs Catalyst Flex helped support a niche contract research organization (CRO) with resources across multiple global studies ensuring the CRO was able to meet its clients’ needs via a cost-effective solution. Read Now 
Biometric Services for Large Pharmaceutical Company Catalyst Flex helped a global biopharmaceutical company with biometric resources to support its large portfolio of studies. Read Now 
Successful Global Site Engagement Solution Customized site engagement solution designed to meet the unique needs of a global pharmaceutical company. Read Now 
Assisting a Large Global Sponsor for Oncology Studies Catalyst Flex helped a global pharmaceutical company with resources for its large portfolio of studies. Catalyst Flex quickly stepped in to provide a team of talented individuals with the functional expertise required to deliver our client’s projects. Read Now 
Oversight Monitoring Successes A biopharmaceutical company engaged Catalyst Flex to provide appropriate and impartial oversight monitoring for several studies. Such services can help to prevent a sponsor from receiving findings during U.S. Food and Drug Administration (FDA) audits and in particular any Form FDA 483. Read Now 
Comprehensive and Flexible Partnership to Support Rescue Study A biotech company new to clinical research with an asset early in its development lifecycle became a long-term partner with Catalyst Flex. For years, Catalyst has worked alongside to help achieve the client’s goals for a single asset for the first bladder cancer therapy on the horizon in the past 20 years. Read Now